What it’s for
- Studied for mitochondrial biomarkers
- Studied for muscle endurance in middle-aged and older adults
A gut-microbe metabolite of ellagitannins, sold directly as a synthetic postbiotic and studied for mitochondrial and muscle outcomes.
Purpose, evidence and practical considerations.
Sponsored short-term trials show target engagement and some endurance signals, but strength, aerobic-capacity and longevity benefits remain unestablished. Long-term independent evidence is limited.
Confidence: weak
Short sponsored trials report acceptable tolerability, but long-term safety and clinical-outcome evidence are limited. Product claims should disclose the industry-funded evidence base.
Urolithin A supplies a nutrient or bioactive compound intended to alter a defined physiological pathway. The relevant form, baseline status and product quality determine whether the proposed mechanism is clinically meaningful.
Regulatory status: dietary supplement (US); proposed novel-food ingredient (EU/UK, not authorised as of this review — see section 7). Not a medication. Not a device
How people use it, with their schedules, context and original sources.
500–1000 mg · regularly · any time of day, with or without food
improves mitophagy; human trials show increased strength
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
1 public example — useful context, not a reliable distribution.
1 public example — useful context, not a reliable distribution.
1 public example — useful context, not a reliable distribution.
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
Reviewed branded products and distinct forms related to Urolithin A. A listing is not an endorsement.
Timeline (Mitopure)
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.
mitochondrial health, as part of what he does to protect cognition